Previous Close | 3.6400 |
Open | 3.6700 |
Bid | 0.0000 x 1300 |
Ask | 0.0000 x 800 |
Day's Range | 3.2700 - 3.7100 |
52 Week Range | 2.5500 - 13.3500 |
Volume | |
Avg. Volume | 2,458,600 |
Market Cap | 812.336M |
Beta (5Y Monthly) | 0.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for GOEV
Though the broader market volatility has presented intriguing, discounted opportunities, some ideas are simply stocks to avoid. Novavax (NVAX) — A huge winner during the height of the coronavirus pandemic, the resultant societal fatigue makes NVAX too risky for conservative investors. Teladoc Health (TDOC) — While TDOC has given up all of its post-pandemic gains and then some, the lack of current relevance hurts the telehealth sector. GrowGeneration (GRWG) — Unfortunately, the black market for “
Start of production by electric vehicle maker Canoo Inc at its Arkansas and Oklahoma assembly plants could slip due to supply-chain pressures, but its chief executive remains bullish on the company's ability to raise money. The global chip shortage and higher material costs could, in a worst-case scenario, delay start of vehicle production at Canoo's Arkansas plant by a few weeks into early next year from the fourth quarter this year, CEO Tony Aquila said Wednesday. In addition, start of production at Canoo's planned plant in Oklahoma could slip from late 2023 into 2024, he said.
While Rivian (RIVN) and Lordstown (RIDE) post a narrower-than-expected loss in Q1, ElectraMeccanica (SOLO), Canoo (GOEV) and Workhorse (WKHS) incur a wider-than-anticipated loss.